CHRISTOPHER B. COOPER,DOONGFENG ZHANG,HAIHONG HUANG,NADER FOTOUHI,TAKUSHI KANEKO
申请号：
BR112018000991
公开号：
BR112018000991A2
申请日:
2016.07.15
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
